Innovative Surgery for Obstructive Sleep Apnea: Nerve Stimulator

2017 ◽  
pp. 116-124
Author(s):  
J. Ulrich Sommer ◽  
Karl Hörmann
Keyword(s):  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
Nerve Stimulator ◽  
Obstructive Sleep

POSSIBLE NEW ETIOLOGY FOR THE VAGUS NERVE STIMULATOR CAUSING OBSTRUCTIVE SLEEP APNEA

CHEST Journal ◽  
2006 ◽  
Vol 130 (4) ◽  
pp. 346S
Author(s):  
Marwan Mouammar ◽  
Rose Franco ◽  
B. Tucker Woodson ◽  
Tarif Smadi ◽  
Humberto Battistini
Keyword(s):  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
Vagus Nerve ◽  
Nerve Stimulator ◽  
Vagus Nerve Stimulator ◽  
Obstructive Sleep

853 Severe Obstructive Sleep Apnea after Treatment with Phrenic Nerve Implant for Central Sleep Apnea: A Case for Dual Stimulation?

SLEEP ◽  
2021 ◽  
Vol 44 (Supplement_2) ◽  
pp. A332-A332
Author(s):  
Sarah Sussman ◽  
Ashwin Ananth ◽  
Elie Fares ◽  
Colin Huntley ◽  
Maurits Boon ◽  
...  
Keyword(s):  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
Nerve Stimulation ◽  
Phrenic Nerve ◽  
Hypoglossal Nerve ◽  
Central Sleep Apnea ◽  
Implantable Devices ◽  
Nerve Stimulator ◽  
Phrenic Nerve Stimulation ◽  
Obstructive Sleep

Abstract Introduction The remedē® system is a transvenous phrenic nerve stimulator used to treat central sleep apnea (CSA). It is a safe and effective implantable device that has demonstrated significant improvements in objective sleep and quality of life. While complex sleep apnea represents development of central sleep apnea during treatment with continuous positive airway pressure (CPAP) for obstructive sleep apnea, and has been well-described in the literature, we present a novel case of predominantly central sleep apnea treated with phrenic nerve stimulation with augmentation of obstructive events thereafter. This patient is, at the time of submission, being evaluated for hypoglossal nerve stimulation. Report of case(s) A 63-year-old male patient with a past medical history of hypertension, atrial fibrillation, asthma, chronic obstructive pulmonary disease, GERD, obesity, and prior pulmonary embolism presented to the sleep medicine clinic with complaints of difficulty initiating and maintaining sleep, snoring, multiple nocturnal awakenings, excessive daytime sleepiness, and physical fatigue. On exam, BMI was 30.4, and airway classification was Mallampati 4. Split night polysomnography revealed severe mixed sleep apnea with an overall apnea hypopnea index (AHI) of 58.6 and a central AHI of 53.8 per hour after successful PAP titration at 7 cm H2O. He underwent phrenic nerve stimulator implantation and activation without complications. Phrenic nerve stimulation titration study four months after activation showed a normal central AHI of 4.6 per hour at a therapeutic voltage of 1.6 to 1.9mA, but significantly worse OSA with obstructive AHI of 53.1. In follow up, he reported intolerance of CPAP due to significant nasal congestion as well as asthma. Presently, he is scheduled for drug induced sleep endoscopy to visualize airway obstruction and is being evaluated for Inspire hypoglossal nerve stimulation and nasal surgery. Conclusion The treatment of sleep apnea has recently evolved rapidly with the development of implantable devices to treat both central and obstructive sleep apnea. We present a novel case of the first known patient to be considered for dual nerve stimulation for sleep apnea. Further study needs to be done to determine the safety and efficacy of concurrent implantable devices for the simultaneous treatment of OSA and CSA. Support (if any):

scholarly journals Implantation of the nyxoah bilateral hypoglossal nerve stimulator for obstructive sleep apnea

2019 ◽  
Vol 4 (6) ◽  
pp. 703-707 ◽  
Author(s):  
Richard Lewis ◽  
Boris Pételle ◽  
Matthew C. Campbell ◽  
Stuart MacKay ◽  
Carsten Palme ◽  
...  
Keyword(s):  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
Hypoglossal Nerve ◽  
Nerve Stimulator ◽  
Obstructive Sleep

scholarly journals Use and Cost of a Hypoglossal Nerve Stimulator Device for Obstructive Sleep Apnea Between 2015 and 2018

2019 ◽  
Vol 145 (10) ◽  
pp. 975 ◽  
Author(s):  
Vinay K. Rathi ◽  
Neil S. Kondamuri ◽  
Matthew R. Naunheim ◽  
Shekhar K. Gadkaree ◽  
Ralph B. Metson ◽  
...  
Keyword(s):  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
Hypoglossal Nerve ◽  
Nerve Stimulator ◽  
Obstructive Sleep

scholarly journals 1226 A Case of Hypoglossal Nerve Stimulation Induced Cheyne-Stoke Central Sleep Apnea

SLEEP ◽  
2020 ◽  
Vol 43 (Supplement_1) ◽  
pp. A468-A468
Author(s):  
Talayeh Rezayat ◽  
Melisa Chang
Keyword(s):  
Heart Failure ◽  
Obstructive Sleep Apnea ◽  
Sleep Apnea ◽  
Nerve Stimulation ◽  
Hypoglossal Nerve ◽  
Central Sleep Apnea ◽  
Nerve Stimulator ◽  
Hypoglossal Nerve Stimulation ◽  
Obstructive Sleep ◽  
History Of

Abstract Introduction Treatment of obstructive sleep apnea (OSA) with positive airway pressure (PAP), mandibular advancement devices (MAD) and oral surgery have been reported to lead to emergent central sleep apnea (CSA). In this case report the emergence of CSA in a Cheyne-Stokes pattern following the use of hypoglossal nerve stimulator as a treatment modality for OSA is discussed. Report of Case A 70-year-old man with a history of hypothyroidism and severe OSA diagnosed via a home sleep apnea test with a respiratory event index (REI) of 38 events/ hr was intolerant of PAP therapy and an MAD did not effectively treat his OSA. He was deemed an appropriate candidate for hypoglossal nerve stimulation following a drug induced sleep endoscopy. Following implantation and activation, he developed a lip droop and was ruled out for a stroke. A polysomnogram was completed which showed significant improvement in his sleep apnea at a voltage range of 1.4-17V. At 1.8V he developed REM- supine central events. When the voltage was further increased to 1.9-2.0V non-REM supine central events arose. These events appeared to have Cheyne-Stoke morphology with a cycle duration of over 50s. He was set to an amplitude of 1.6 V with a positional belt for treatment of his OSA without any emergent CSA. Conclusion This patient developed central sleep apneas with Cheyne-Stoke morphology following treatment of obstructive sleep apnea using a hypoglossal nerve stimulator. The central events began at higher voltage settings (greater than 1.8V). He had no history of heart failure or arrhythmias. This higher voltage may lead to overshoot of the tongue out of the airway resulting in hyperpnea, hypocapnia and central apnea but the underlying pathophysiology for the Cheyne-Stoke pattern in the absence of heart failure remains unknown.

Sign in / Sign up

Export Citation Format

Share Document